Dissecting Clonal Heterogeneity in AML. (2020)

First Author: Schuringa JJ
Attributed to:  Finding therapeutic targets in FLT3-ITD AML using a systems biology approach funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ccell.2020.11.011

PubMed Identifier: 33321087

Publication URI: http://europepmc.org/abstract/MED/33321087

Type: Journal Article/Review

Volume: 38

Parent Publication: Cancer cell

Issue: 6

ISSN: 1535-6108